BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
Number Citing Articles
1 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Reference Citation Analysis]
2 Marinelli F, Caporilli C, Titolo A, Rigante D, Esposito S. Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever. Pharmacol Res 2022;182:106293. [PMID: 35690330 DOI: 10.1016/j.phrs.2022.106293] [Reference Citation Analysis]
3 Hua S, Yang Y, Zou D, Li J, Yan K, Xu Y, Jiang X, Rong X, Ye D. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed Pharmacother 2021;140:111685. [PMID: 34015585 DOI: 10.1016/j.biopha.2021.111685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Khadka D, Dhamala MK, Li F, Aryal PC, Magar PR, Bhatta S, Thakur MS, Basnet A, Cui D, Shi S. The use of medicinal plants to prevent COVID-19 in Nepal. J Ethnobiol Ethnomed 2021;17:26. [PMID: 33832492 DOI: 10.1186/s13002-021-00449-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Paull JRA, Luscombe CA, Castellarnau A, Heery GP, Bobardt MD, Gallay PA. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses 2021;13:1656. [PMID: 34452519 DOI: 10.3390/v13081656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Alberti A, Schuelter-Trevisol F, Iser BPM, Traebert E, Freiberger V, Ventura L, Rezin GT, da Silva BB, Meneghetti Dallacosta F, Grigollo L, Dias P, Fin G, De Jesus JA, Pertille F, Rossoni C, Hur Soares B, Nodari Júnior RJ, Comim CM. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken. World J Clin Cases 2021; 9(20): 5358-5371 [PMID: 34307590 DOI: 10.12998/wjcc.v9.i20.5358] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pereira GJDS, Leão AHFF, Erustes AG, Morais IBM, Vrechi TAM, Zamarioli LDS, Pereira CAS, Marchioro LO, Sperandio LP, Lins ÍVF, Piacentini M, Fimia GM, Reckziegel P, Smaili SS, Bincoletto C. Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. Int J Mol Sci 2021;22:4067. [PMID: 33920748 DOI: 10.3390/ijms22084067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
8 Picod A, Dinkelacker V, Savatovsky J, Trouiller P, Guéguen A, Engrand N. SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism. Crit Care 2020;24:658. [PMID: 33228760 DOI: 10.1186/s13054-020-03389-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Panariello F, Cellini L, Speciani M, De Ronchi D, Atti AR. How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis. Front Psychiatry 2020;11:582345. [PMID: 33304284 DOI: 10.3389/fpsyt.2020.582345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hajimohammadebrahim-Ketabforoush M, Shahmohammadi MR, Zali A, Vahdat Shariatpanahi Z. COVID-19-associated stroke risk: Could nutrition and dietary patterns have a contributing role? World J Meta-Anal 2020; 8(6): 435-446 [DOI: 10.13105/wjma.v8.i6.435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Shakeeb N, Varkey P, Hynse A, Ajit A. Saliva as a Potential Specimen to Monitor IL-6, TNF-α and IL-10 in COVID-19 Patients. Inflammation 2022. [PMID: 35676607 DOI: 10.1007/s10753-022-01698-x] [Reference Citation Analysis]
13 Drelich-zbroja A, Cheda M, Kuczyńska M, Dąbrowska I, Kopyto E, Halczuk I. Parkinson’s Disease in Light of the COVID-19 Pandemic. Brain Sciences 2022;12:143. [DOI: 10.3390/brainsci12020143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sharma D, Spring KJ, Bhaskar SMM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis. Acta Neurol Scand 2021;144:486-99. [PMID: 34190348 DOI: 10.1111/ane.13493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
15 Li L, Wu Y, Wang J, Yan H, Lu J, Wan Y, Zhang B, Zhang J, Yang J, Wang X, Zhang M, Li Y, Miao L, Zhang H. Potential treatment of COVID-19 with traditional chinese medicine: What herbs can help win the battle with SARS-CoV-2? Engineering (Beijing) 2021. [PMID: 34729244 DOI: 10.1016/j.eng.2021.08.020] [Reference Citation Analysis]
16 Ruscica M, Penson PE, Ferri N, Sirtori CR, Pirro M, Mancini GBJ, Sattar N, Toth PP, Sahebkar A, Lavie CJ, Wong ND, Banach M; International Lipid Expert Panel (ILEP) and International Lipid Expert Panel Experts (alphabetically). Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis 2021;67:40-52. [PMID: 34186099 DOI: 10.1016/j.pcad.2021.06.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 23.0] [Reference Citation Analysis]
17 Cryer MJ, Farhan S, Kaufmann CC, Jäger B, Garg A, Krishnan P, Mehran R, Huber K. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review. Clin Appl Thromb Hemost 2022;28:107602962210743. [DOI: 10.1177/10760296221074353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Rabbani MY, Rappaport J, Gupta MK. Activation of Immune System May Cause Pathophysiological Changes in the Myocardium of SARS-CoV-2 Infected Monkey Model. Cells 2022;11:611. [DOI: 10.3390/cells11040611] [Reference Citation Analysis]
19 Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, Guest PC, Majeed M, Mohammadi A, Banach M, Jamialahmadi T, Sahebkar A. Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients 2022;14:256. [PMID: 35057437 DOI: 10.3390/nu14020256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
20 Mahalakshmi AM, Ray B, Tuladhar S, Bhat A, Paneyala S, Patteswari D, Sakharkar MK, Hamdan H, Ojcius DM, Bolla SR, Essa MM, Chidambaram SB, Qoronfleh MW. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis 2021;9:48-58. [PMID: 33332737 DOI: 10.1002/iid3.387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
21 Song T, Hayanga J, Durham L, Garrison L, McCarthy P, Barksdale A, Smith D, Bartlett R, Jaros M, Nelson P, Molnar Z, Deliargyris E, Moazami N. CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry. Front Med (Lausanne) 2021;8:773461. [PMID: 34988092 DOI: 10.3389/fmed.2021.773461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Tahyra ASC, Calado RT, Almeida F. The Role of Extracellular Vesicles in COVID-19 Pathology. Cells 2022;11:2496. [DOI: 10.3390/cells11162496] [Reference Citation Analysis]
23 Ghanei M. It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window? Arch Med Sci 2021;17:546-50. [PMID: 33747291 DOI: 10.5114/aoms/130647] [Reference Citation Analysis]
24 Kumar A, Sharma A, Tirpude NV, Sharma S, Padwad YS, Kumar S. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection. Inflammopharmacol. [DOI: 10.1007/s10787-021-00903-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Majeed M, Nagabhushanam K, Prakasan P, Mundkur L. Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review. Int J Mol Sci 2022;23:4809. [PMID: 35563199 DOI: 10.3390/ijms23094809] [Reference Citation Analysis]
26 Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, León-Aguilar AM, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Corniel-Taveras CN, Dominguez-García JJ, Blanco-Alvarez VM, Luna-Muñoz J. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front Neurol 2021;12:660087. [PMID: 33912129 DOI: 10.3389/fneur.2021.660087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 Bhaskar S, Rastogi A, Menon KV, Kunheri B, Balakrishnan S, Howick J. Call for Action to Address Equity and Justice Divide During COVID-19. Front Psychiatry 2020;11:559905. [PMID: 33343410 DOI: 10.3389/fpsyt.2020.559905] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
28 Mahler M, Meroni PL, Infantino M, Buhler KA, Fritzler MJ. Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Rev Clin Immunol 2021;17:431-43. [PMID: 33750254 DOI: 10.1080/1744666X.2021.1905526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
29 Khaled JMA. Probiotics, prebiotics, and COVID-19 infection: A review article. Saudi J Biol Sci 2021;28:865-9. [PMID: 33424377 DOI: 10.1016/j.sjbs.2020.11.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Sherazi A, Bedi P, Udevbulu E, Rubin V, Alasadi L, Spitalewitz S. Hyponatremia and Encephalopathy in a 55-Year-old Woman with Syndrome of Inappropriate Antidiuretic Hormone Secretion as an Isolated Presentation of SARS-CoV-2 Infection. Am J Case Rep 2021;22:e930135. [PMID: 33760803 DOI: 10.12659/AJCR.930135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tanaka S, Yamamoto K, Hagiya H, Hasegawa K, Otsuka F. High-dose steroids for the treatment of severe COVID-19: comment. Intern Emerg Med 2021;16:1415-6. [PMID: 34037928 DOI: 10.1007/s11739-021-02766-0] [Reference Citation Analysis]
32 Ouyang W, Xie T, Fang H, Gao C, Stantchev T, Clouse KA, Yuan K, Ju T, Frucht DM. Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo. Int J Mol Sci 2021;22:7540. [PMID: 34299155 DOI: 10.3390/ijms22147540] [Reference Citation Analysis]
33 Bonnet B, Cosme J, Dupuis C, Coupez E, Adda M, Calvet L, Fabre L, Saint-Sardos P, Bereiziat M, Vidal M, Laurichesse H, Souweine B, Evrard B. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine 2021;73:103622. [PMID: 34678611 DOI: 10.1016/j.ebiom.2021.103622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Iwamura APD, Tavares da Silva MR, Hümmelgen AL, Soeiro Pereira PV, Falcai A, Grumach AS, Goudouris E, Neto AC, Prando C. Immunity and inflammatory biomarkers in COVID-19: A systematic review. Rev Med Virol 2021;31:e2199. [PMID: 34260778 DOI: 10.1002/rmv.2199] [Reference Citation Analysis]
35 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
36 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hsu RJ, Yu WC, Peng GR, Ye CH, Hu S, Chong PCT, Yap KY, Lee JYC, Lin WC, Yu SH. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Front Immunol 2022;13:832394. [PMID: 35464491 DOI: 10.3389/fimmu.2022.832394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Heida R, Hinrichs WL, Frijlink HW. Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert Rev Vaccines 2021;:1-18. [PMID: 33749491 DOI: 10.1080/14760584.2021.1903878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Esmaeilzadeh A, Elahi R. Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J Cell Physiol 2021;236:2519-43. [PMID: 33022076 DOI: 10.1002/jcp.30076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
40 Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases 2020; 8(21): 5250-5283 [PMID: 33269260 DOI: 10.12998/wjcc.v8.i21.5250] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 22] [Article Influence: 17.0] [Reference Citation Analysis]
41 Olszewska-Parasiewicz J, Szarpak Ł, Rogula S, Gąsecka A, Szymańska U, Kwiatkowska M, Jaguszewski MJ, Sierpiński R, Zaczyński A, Wierzba W, Kosior DA. Statins in COVID-19 Therapy. Life (Basel) 2021;11:565. [PMID: 34208435 DOI: 10.3390/life11060565] [Reference Citation Analysis]
42 van Kempen TATG, Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19. Am J Physiol Endocrinol Metab 2021;320:E2-6. [PMID: 33174766 DOI: 10.1152/ajpendo.00474.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
43 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
44 Yao L, Lu L, Ma W. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients. Heliyon 2022;8:e09302. [PMID: 35497026 DOI: 10.1016/j.heliyon.2022.e09302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Welzel T, Samba SD, Klein R, van den Anker JN, Kuemmerle-Deschner JB. COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment. J Clin Med 2021;10:605. [PMID: 33562758 DOI: 10.3390/jcm10040605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
46 Lam C, Siefkas A, Zelin NS, Barnes G, Dellinger RP, Vincent JL, Braden G, Burdick H, Hoffman J, Calvert J, Mao Q, Das R. Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids. Clin Ther 2021:S0149-2918(21)00128-4. [PMID: 33865643 DOI: 10.1016/j.clinthera.2021.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sharma D, Bhaskar S. Addressing the Covid-19 Burden on Medical Education and Training: The Role of Telemedicine and Tele-Education During and Beyond the Pandemic. Front Public Health 2020;8:589669. [PMID: 33330333 DOI: 10.3389/fpubh.2020.589669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
48 Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, El-Saber Batiha G. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol 2021;904:174196. [PMID: 34004207 DOI: 10.1016/j.ejphar.2021.174196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Satarker S, Tom AA, Shaji RA, Alosious A, Luvis M, Nampoothiri M. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy. Postgrad Med 2021;133:489-507. [PMID: 33245005 DOI: 10.1080/00325481.2020.1855921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
50 Rezabakhsh A, Sadat-Ebrahimi SR, Ala A, Nabavi SM, Banach M, Ghaffari S. A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system. J Cell Mol Med 2021. [PMID: 34894069 DOI: 10.1111/jcmm.17122] [Reference Citation Analysis]
51 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
52 Al Bishawi A, Abdalla S, Askar M, Kanjo W, Sameer A, Mustafa G, Abdel Hadi H, Al Maslamani M, Abdelmajid A. Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5932] [Reference Citation Analysis]
53 Barzkar F, Ranjbar M, Sioofy-Khojine AB, Khajehazad M, Vesal Azad R, Moradi Y, Baradaran HR. Efficacy and safety of chloroquine and hydroxychloroquine for COVID-19: A comprehensive evidence synthesis of clinical, animal, and in vitro studies. Med J Islam Repub Iran 2020;34:171. [PMID: 33816370 DOI: 10.47176/mjiri.34.171] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, Yusof AHA, Sagadevan S, Hazafa A, Uddin J, Khan A, Al-harrasi A. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules 2022;12:971. [DOI: 10.3390/biom12070971] [Reference Citation Analysis]
56 Surma S, Banach M, Lewek J. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection. Lipids Health Dis 2021;20:141. [PMID: 34689776 DOI: 10.1186/s12944-021-01563-0] [Reference Citation Analysis]
57 Chandler CM, Reid MC, Cherian S, Sabath DE, Edlefsen KL. Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA. Am J Clin Pathol 2021;156:185-97. [PMID: 34151348 DOI: 10.1093/ajcp/aqab052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Concepción-Zavaleta MJ, Ildefonso-Najarro SP, Plasencia-Dueñas E, Coronado Arroyo JC, Zavaleta-Gutiérrez FE, Concepción-Urteaga L, Massucco Revoredo F, Ramos-Yataco A, Meza K. Bilateral Neonatal Adrenal Hemorrhage Associated With Severe Maternal COVID-19 Infection. Cureus 2021;13:e20007. [PMID: 34987898 DOI: 10.7759/cureus.20007] [Reference Citation Analysis]
59 Shakeeb N, Varkey P, Hynse A, Mandlecha A. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR. Inflammopharmacology 2022. [PMID: 35320494 DOI: 10.1007/s10787-022-00951-x] [Reference Citation Analysis]
60 Vinson AJ, Dai R, Agarwal G, Anzalone AJ, Lee SB, French E, Olex AL, Madhira V, Mannon RB; National COVID Cohort Collaborative (N3C) Consortium. Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19. Am J Transplant 2021. [PMID: 34637599 DOI: 10.1111/ajt.16865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
61 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Delinasios GJ, Fragkou PC, Gkirmpa AM, Tsangaris G, Hoffman RM, Anagnostopoulos AK. The Experience of Greece as a Model to Contain COVID-19 Infection Spread. In Vivo 2021;35:1285-94. [PMID: 33622932 DOI: 10.21873/invivo.12380] [Reference Citation Analysis]
63 Aliyu M, Mozhgani S, Gargari OK, Yusuf MA, Saboor-yaraghi AA; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, International Campus, TUMS-IC, Tehran, Iran, Department of Medical Microbiology and Parasitology, Faculty of Clinical Science, College of Health Sciences, Bayero University, Kano, Nigeria, Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran, Non-communicable Diseases Research Centre Alborz University of Medical Sciences, Karaj, Iran, Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. . ALLERGY 2021;5:240-58. [DOI: 10.3934/allergy.2021018] [Reference Citation Analysis]
64 Tonello S, Rizzi M, Matino E, Costanzo M, Casciaro GF, Croce A, Rizzi E, Zecca E, Pedrinelli A, Vassia V, Landi R, Bellan M, Castello LM, Minisini R, Mallela VR, D’onghia D, Avanzi GC, Pirisi M, Lilleri D, Sainaghi PP, González A. Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients. Disease Markers 2022;2022:1-7. [DOI: 10.1155/2022/1568352] [Reference Citation Analysis]
65 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
66 Bianconi V, Mannarino MR, Figorilli F, Cosentini E, Batori G, Marini E, Banach M, Sahebkar A, Pirro M. The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19. Expert Rev Mol Diagn 2022. [PMID: 35260036 DOI: 10.1080/14737159.2022.2052047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Truong CT, Huynh KH, Duong VT, Nguyen HH, Pham LA, Nguyen TT; National Key Laboratory of Digital Control and System Engineering (DCSELAB), HCMUT, VNU-HCM, The Department of Mechatronics, Ho Chi Minh City University of Technology, VNU-HCM, Faculty of Electronics and Telecommunication, Saigon University, Vietnam, Grant and Innovation Center (GIC), University of Medicine and Pharmacy, Ho Chi Minh city. . AIMS Bioengineering 2021;8:192-207. [DOI: 10.3934/bioeng.2021017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kuwana T, Kinoshita K, Hirabayashi M, Ihara S, Sawada N, Mutoh T, Yamaguchi J. PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series. Infect Drug Resist 2021;14:1305-10. [PMID: 33854342 DOI: 10.2147/IDR.S299023] [Reference Citation Analysis]
69 Shi C, Killingsworth MC, Bhaskar SMM. Prognostic capacity of hyperdense middle cerebral artery sign in anterior circulation acute ischaemic stroke patients receiving reperfusion therapy: a systematic review and meta-analysis. Acta Neurol Belg 2022;122:423-35. [PMID: 34095978 DOI: 10.1007/s13760-021-01720-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
70 Mizurini DM, Hottz ED, Bozza PT, Monteiro RQ. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects. Front Cardiovasc Med 2021;8:785738. [PMID: 34977191 DOI: 10.3389/fcvm.2021.785738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
71 Zhang HX, Zhang X. Network pharmacology and experimental validation identify the potential mechanism of sophocarpine for COVID-19. J Med Microbiol 2022;71. [PMID: 35622496 DOI: 10.1099/jmm.0.001538] [Reference Citation Analysis]
72 Dafni M, Karampeli M, Michelakis I, Manta A, Spanoudaki A, Mantzos D, Krontira S, Georgiadou V, Lioni A, Tzavara V. Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasone. J Investig Med 2022:jim-2021-002274. [PMID: 35379701 DOI: 10.1136/jim-2021-002274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, Socorro de Barros Viana G. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? Rev Neurosci 2021;32:235-47. [PMID: 33185582 DOI: 10.1515/revneuro-2020-0074] [Reference Citation Analysis]
74 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Markovic SS, Jovanovic M, Gajovic N, Jurisevic M, Arsenijevic N, Jovanovic M, Jovanovic M, Mijailovic Z, Lukic S, Zornic N, Vukicevic V, Stojanovic J, Maric V, Jocic M, Jovanovic I. IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding. Front Med (Lausanne) 2021;8:749569. [PMID: 34917631 DOI: 10.3389/fmed.2021.749569] [Reference Citation Analysis]
76 Liu G, Jiang C, Lin X, Yang Y. Point-of-care detection of cytokines in cytokine storm management and beyond: Significance and challenges. View (Beijing) 2021;:20210003. [PMID: 34766163 DOI: 10.1002/VIW.20210003] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Tamir H, Melamed S, Erez N, Politi B, Yahalom-ronen Y, Achdout H, Lazar S, Gutman H, Avraham R, Weiss S, Paran N, Israely T. Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection. Viruses 2022;14:189. [DOI: 10.3390/v14020189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Katyal A, Bhaskar S. CTP-guided reperfusion therapy in acute ischemic stroke: a meta-analysis. Acta Neurol Scand 2021;143:355-66. [PMID: 33188539 DOI: 10.1111/ane.13374] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
79 Cabaro S, D'Esposito V, Di Matola T, Sale S, Cennamo M, Terracciano D, Parisi V, Oriente F, Portella G, Beguinot F, Atripaldi L, Sansone M, Formisano P. Cytokine signature and COVID-19 prediction models in the two waves of pandemics. Sci Rep 2021;11:20793. [PMID: 34675240 DOI: 10.1038/s41598-021-00190-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Cho HJ, Baek DW, Kim J, Lee JM, Moon JH, Sohn SK. Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions. Expert Rev Hematol 2021;:1-12. [PMID: 34375536 DOI: 10.1080/17474086.2021.1967139] [Reference Citation Analysis]
81 Hwang ST, Ballout AA, Mirza U, Sonti AN, Husain A, Kirsch C, Kuzniecky R, Najjar S. Acute Seizures Occurring in Association With SARS-CoV-2. Front Neurol 2020;11:576329. [PMID: 33224090 DOI: 10.3389/fneur.2020.576329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S; CNS SARS-CoV-2 Consortium. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimers Dement 2021;17:1056-65. [PMID: 33399270 DOI: 10.1002/alz.12255] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
83 Onaolapo A, Onaolapo O. COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration? CNS Neurol Disord Drug Targets 2021. [PMID: 34951374 DOI: 10.2174/1871527321666211222162811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Lewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study. Arch Med Sci 2021;17:818-22. [PMID: 34025853 DOI: 10.5114/aoms/134211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Dzobo K, Chiririwa H, Dandara C, Dzobo W. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine. OMICS 2021;25:13-22. [PMID: 32857671 DOI: 10.1089/omi.2020.0122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Chen PK, Chen DY. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics. J Immunol Res 2021;2021:8998358. [PMID: 34239943 DOI: 10.1155/2021/8998358] [Reference Citation Analysis]
87 Bradley SA, Spring KJ, Beran RG, Chatzis D, Killingsworth MC, Bhaskar SMM. Role of diabetes in stroke: Recent advances in pathophysiology and clinical management. Diabetes Metab Res Rev 2021;:e3495. [PMID: 34530485 DOI: 10.1002/dmrr.3495] [Reference Citation Analysis]
88 Ad’hiah AH, Abdullah MH, Alsudani MY, Shnawa RMS, Al-sa’ady AJR, Allami RH, Misha’al KI, Jassim IA, Taqi EA. Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00115-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Ouyang Y, Bagalkot T, Fitzgerald W, Sadovsky E, Chu T, Martínez-Marchal A, Brieño-Enríquez M, Su EJ, Margolis L, Sorkin A, Sadovsky Y. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin. mSphere 2021;6:e00250-21. [PMID: 33853873 DOI: 10.1128/mSphere.00250-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
90 Spinetti G, Avolio E, Madeddu P. Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? Regen Med 2021;16:477-94. [PMID: 33988482 DOI: 10.2217/rme-2020-0189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Cui Y, Sun Y, Sun J, Liang H, Ding X, Sun X, Wang D, Sun T. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Infect Dis Ther 2021. [PMID: 34389970 DOI: 10.1007/s40121-021-00518-3] [Reference Citation Analysis]
92 Tandon S, Aggarwal A, Jain S, Shukla S, Chaudhary S. Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19. Protein J 2020;39:631-43. [PMID: 33034824 DOI: 10.1007/s10930-020-09921-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
94 de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin. EMBO Mol Med 2021;13:e14122. [PMID: 34170074 DOI: 10.15252/emmm.202114122] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Sun W, Gao H, Luo Y, Zheng H, Liao X, Xiong D, Xiao L. Management of Immunity Alteration-Induced Chronic Pain During the Coronavirus Disease-2019 (COVID-19) Pandemic. Front Microbiol 2020;11:572318. [PMID: 33072033 DOI: 10.3389/fmicb.2020.572318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Xu J, Xiao W, Liang X, Zhang P, Shi L, Wang Y, Wang Y, Yang H. The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates. J Stroke Cerebrovasc Dis 2020;29:105283. [PMID: 33066922 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105283] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
97 Das D, Podder S. Deregulation of ceRNA Networks in Frontal Cortex and Choroid Plexus of Brain during SARS-CoV-2 Infection Aggravates Neurological Manifestations: An Insight from Bulk and Single-Cell Transcriptomic Analyses. Adv Biol (Weinh) 2022;:e2101310. [PMID: 35661455 DOI: 10.1002/adbi.202101310] [Reference Citation Analysis]
98 Wang JH, Chen RD, Yang HK, Zeng LC, Chen H, Hou YY, Hu W, Yu JS, Li H. Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19. J Med Virol 2021;93:2908-17. [PMID: 33393678 DOI: 10.1002/jmv.26771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
99 Chen Z, Wang X, Li L, Han M, Wang M, Li Z, Xie X, Du H, Xie Z, Zhang H. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo. Microb Pathog 2021;158:105051. [PMID: 34153417 DOI: 10.1016/j.micpath.2021.105051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Montini F, Martinelli V, Sangalli F, Callea M, Anzalone N, Filippi M. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia. Neurol Sci 2021. [PMID: 34273051 DOI: 10.1007/s10072-021-05472-z] [Reference Citation Analysis]
101 Bahouth MN, Venkatesan A. Acute Viral Illnesses and Ischemic Stroke: Pathophysiological Considerations in the Era of the COVID-19 Pandemic. Stroke 2021;52:1885-94. [PMID: 33794653 DOI: 10.1161/STROKEAHA.120.030630] [Reference Citation Analysis]
102 Briguglio M, Porta M, Zuffada F, Bona AR, Crespi T, Pino F, Perazzo P, Mazzocchi M, Giorgino R, De Angelis G, Ielasi A, De Blasio G, Turiel M. SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19. Front Physiol 2020;11:571367. [PMID: 33240098 DOI: 10.3389/fphys.2020.571367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
103 Chen PK, Lan JL, Huang PH, Hsu JL, Chang CK, Tien N, Lin HJ, Chen DY. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19. Front Immunol 2021;12:719544. [PMID: 34367188 DOI: 10.3389/fimmu.2021.719544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Malinverni S, Nuñez M, Cotton F, Martiny D, Collot V, Konopnicki D, Alard S, Bartiaux M. Is procalcitonin a reliable marker of bacterial community-acquired pneumonia in adults admitted to the emergency department during SARS-CoV-2 pandemic? Eur J Emerg Med 2021;28:312-4. [PMID: 34187994 DOI: 10.1097/MEJ.0000000000000796] [Reference Citation Analysis]
105 Tong DM, Zhou YT, Wang YW. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis. J Clin Med Res 2021;13:82-91. [PMID: 33747322 DOI: 10.14740/jocmr4437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Li Q, Zhang T, Wang Y, Yang S, Luo J, Fang F, Liao J, Wen W, Cui H, Shang H. Qing-Wen-Jie-Re Mixture Ameliorates Poly (I:C)-Induced Viral Pneumonia Through Regulating the Inflammatory Response and Serum Metabolism. Front Pharmacol 2022;13:891851. [DOI: 10.3389/fphar.2022.891851] [Reference Citation Analysis]
107 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Niazi NS, Nassar TI, Stewart IJ, Honore PM, Sharma K, Chung KK. A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients. ASAIO J 2022. [PMID: 35417433 DOI: 10.1097/MAT.0000000000001761] [Reference Citation Analysis]
109 Sharma D, Bhaskar SMM. Prognostic Role of the Platelet-Lymphocyte Ratio in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy: A Meta-Analysis. J Cent Nerv Syst Dis 2022;14:11795735221110373. [PMID: 35860715 DOI: 10.1177/11795735221110373] [Reference Citation Analysis]
110 Sharma D, Bhaskar SMM. Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalized COVID-19 patients: a systematic review and meta-analysis. APMIS 2021. [PMID: 34894016 DOI: 10.1111/apm.13199] [Reference Citation Analysis]
111 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Yulistiani, Izka A H, Rindang A M, A W P. Tocilizumab therapy in COVID-19 patients. PE. [DOI: 10.46542/pe.2022.222.259262] [Reference Citation Analysis]
113 Tyagi M, Kapoor I, Mahajan C, Gupta N, Prabhakar H. Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review. J Neuroanaesth Crit Care 2022;09:010-5. [DOI: 10.1055/s-0042-1744395] [Reference Citation Analysis]
114 Pérez-Galarza J, Prócel C, Cañadas C, Aguirre D, Pibaque R, Bedón R, Sempértegui F, Drexhage H, Baldeón L. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review. Vaccines (Basel) 2021;9:102. [PMID: 33572702 DOI: 10.3390/vaccines9020102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
115 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
116 Falahi S, Zamanian MH, Feizollahi P, Rezaiemanesh A, Salari F, Mahmoudi Z, Gorgin Karaji A. Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population. Cytokine 2022;154:155889. [PMID: 35461173 DOI: 10.1016/j.cyto.2022.155889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Elkhouly MMN, Elazzab AA, Moghul SS. Bilateral adrenal hemorrhage in a man with severe COVID-19 pneumonia. Radiol Case Rep 2021;16:1438-42. [PMID: 33815638 DOI: 10.1016/j.radcr.2021.03.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
118 [DOI: 10.1101/2020.11.21.392639] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
119 Ayana GM, Merga BT, Birhanu A, Alemu A, Negash B, Dessie Y. Predictors of Mortality Among Hospitalized COVID-19 Patients at a Tertiary Care Hospital in Ethiopia. Infect Drug Resist 2021;14:5363-73. [PMID: 34938084 DOI: 10.2147/IDR.S337699] [Reference Citation Analysis]
120 Bozorgmehr N, Mashhouri S, Perez Rosero E, Xu L, Shahbaz S, Sligl W, Osman M, Kutsogiannis DJ, MacIntyre E, O'Neil CR, Elahi S. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. mBio 2021;12:e00384-21. [PMID: 33947753 DOI: 10.1128/mBio.00384-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Toro A, Ruiz MS, Lage-vickers S, Sanchis P, Sabater A, Pascual G, Seniuk R, Cascardo F, Ledesma-bazan S, Vilicich F, Vazquez E, Gueron G. A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene? Antioxidants 2022;11:276. [DOI: 10.3390/antiox11020276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
122 Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci 2021;269:119010. [PMID: 33454368 DOI: 10.1016/j.lfs.2020.119010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
123 Park Y, Na JY, Cho JY, Oh J, Rhee SJ. Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment. Front Pharmacol 2022;13:842836. [PMID: 35721224 DOI: 10.3389/fphar.2022.842836] [Reference Citation Analysis]
124 Zhu H, Jian Z, Zhong Y, Ye Y, Zhang Y, Hu X, Pu B, Gu L, Xiong X. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition. Front Immunol 2021;12:714943. [PMID: 34367186 DOI: 10.3389/fimmu.2021.714943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
125 Khiali S, Rezagholizadeh A, Entezari-Maleki T. A comprehensive review on sarilumab in COVID-19. Expert Opin Biol Ther 2021;21:615-26. [PMID: 33161757 DOI: 10.1080/14712598.2021.1847269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
126 Zagaliotis P, Petrou A, Mystridis GA, Geronikaki A, Vizirianakis IS, Walsh TJ. Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. IJMS 2022;23:8006. [DOI: 10.3390/ijms23148006] [Reference Citation Analysis]
127 Peng X, Wang Y, Xi X, Jia Y, Tian J, Yu B, Tian J. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm. Cardiovasc Drugs Ther 2021;35:231-47. [PMID: 33404925 DOI: 10.1007/s10557-020-07120-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 de Almeida Chuffa LG, Freire PP, Dos Santos Souza J, de Mello MC, de Oliveira Neto M, Carvalho RF. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations. J Mol Med (Berl) 2021. [PMID: 34741638 DOI: 10.1007/s00109-021-02161-4] [Reference Citation Analysis]
129 Mousavi SZ, Rahmanian M, Sami A. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection. Infect Genet Evol 2020;86:104610. [PMID: 33130005 DOI: 10.1016/j.meegid.2020.104610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
130 Rossi G, Galosi L, Gavazza A, Cerquetella M, Mangiaterra S. Therapeutic approaches to coronavirus infection according to "One Health" concept. Res Vet Sci 2021;136:81-8. [PMID: 33588098 DOI: 10.1016/j.rvsc.2021.02.009] [Reference Citation Analysis]
131 [DOI: 10.1101/2020.11.05.369264] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
132 Martínez-Rueda AJ, Álvarez RD, Méndez-Pérez RA, Fernández-Camargo DA, Gaytan-Arocha JE, Berman-Parks N, Flores-Camargo A, Comunidad-Bonilla RA, Mejia-Vilet JM, Arvizu-Hernandez M, Ramirez-Sandoval JC, Correa-Rotter R, Vega-Vega O. Community- and Hospital-Acquired Acute Kidney Injury in COVID-19: Different Phenotypes and Dismal Prognosis. Blood Purif 2021;:1-11. [PMID: 33744901 DOI: 10.1159/000513948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Vahedian-Azimi A, Mohammadi SM, Heidari Beni F, Banach M, Guest PC, Jamialahmadi T, Sahebkar A. Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci 2021;17:579-95. [PMID: 34025827 DOI: 10.5114/aoms/132950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
134 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
135 Low ZY, Wen Yip AJ, Chow VTK, Lal SK. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression. Rev Med Virol 2021;:e2300. [PMID: 34546610 DOI: 10.1002/rmv.2300] [Reference Citation Analysis]
136 Rizzi M, Costanzo M, Tonello S, Matino E, Casciaro FG, Croce A, Rizzi E, Zecca E, Pedrinelli A, Vassia V, Landi R, Bellan M, Castello LM, Minisini R, Mallela VR, Avanzi GC, Pirisi M, Lilleri D, Sainaghi PP. Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein. Dis Markers 2022;2022:3528312. [PMID: 35242241 DOI: 10.1155/2022/3528312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Suri A, Singh NK, Perumal V. Association of inflammatory biomarker abnormalities with mortality in COVID-19: a meta-analysis. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00733-z] [Reference Citation Analysis]
138 Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci 2021. [PMID: 34087964 DOI: 10.1515/revneuro-2020-0154] [Reference Citation Analysis]
139 Chen Z, Yin X, Tan X, Wang J, Jiang N, Tian M, Li H, Lu Z, Xiong N, Gong Y. Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study. Value in Health 2022. [DOI: 10.1016/j.jval.2021.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
140 Chen CY, Chen WC, Hsu CK, Chao CM, Lai CC. Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol 2021;99:108027. [PMID: 34343937 DOI: 10.1016/j.intimp.2021.108027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Bobkova S, Zhukov A, Protsenko D, Samoylenko V, Tyurin I. Critical appraisal of the "cytokine storm" concept in new coronavirus disease COVID-19. Review. Annals of critical care 2021. [DOI: 10.21320/1818-474x-2021-1-57-68] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
142 Dominic P, Ahmad J, Bhandari R, Pardue S, Solorzano J, Jaisingh K, Watts M, Bailey SR, Orr AW, Kevil CG, Kolluru GK. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol 2021;43:101982. [PMID: 34020311 DOI: 10.1016/j.redox.2021.101982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
143 Soltani Hekmat A, Javanmardi K. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients. J Renin Angiotensin Aldosterone Syst 2021;2021:6824259. [PMID: 34853605 DOI: 10.1155/2021/6824259] [Reference Citation Analysis]
144 Singh E, Matada GSP, Abbas N, Dhiwar PS, Ghara A, Das A. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review. Inflammopharmacology 2021. [PMID: 34373972 DOI: 10.1007/s10787-021-00860-5] [Reference Citation Analysis]
145 Harada K, Ho HE, Cunningham-Rundles C. COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City. Clin Immunol 2021;230:108803. [PMID: 34302970 DOI: 10.1016/j.clim.2021.108803] [Reference Citation Analysis]
146 Sertoglu E, Yucel C, Balık AR, Taşçı C, Bilge S, Ertuğrul MS, Nazaroğlu NK, Ozgurtas T. Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19. Nutrition 2022;96:111581. [DOI: 10.1016/j.nut.2021.111581] [Reference Citation Analysis]
147 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-Latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-Ziółkiewicz D, Cybulska B. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci 2021;17:1447-547. [PMID: 34900032 DOI: 10.5114/aoms/141941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Sanoudou D, Hill MA, Belanger MJ, Arao K, Mantzoros CS. Editorial: Obesity, metabolic phenotypes and COVID-19. Metabolism 2022;:155121. [PMID: 35026232 DOI: 10.1016/j.metabol.2021.155121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
149 Sarriá-Landete AJ, Crespo-Matas JA, Domínguez-Quesada I, Castellanos-Monedero JJ, Marte-Acosta D, Arias-Arias ÁJ. Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection. Med Clin (Barc) 2022:S0025-7753(22)00170-1. [PMID: 35718548 DOI: 10.1016/j.medcli.2022.02.025] [Reference Citation Analysis]
150 Hsieh P, Chao Y, Tsai K, Li C, Tzeng I, Wu Y, Shih CY. Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study. Front Nutr 2022;9:832321. [DOI: 10.3389/fnut.2022.832321] [Reference Citation Analysis]
151 Johnson AM, Barigye R, Saminathan H. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases. Hum Vaccin Immunother 2021;17:2824-40. [PMID: 33974497 DOI: 10.1080/21645515.2021.1908060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
152 Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, Adcock IM. COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol 2021;11:563085. [PMID: 33643932 DOI: 10.3389/fcimb.2021.563085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
153 Aslani M, Mortazavi-Jahromi SS, Mirshafiey A. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs. Int Immunopharmacol 2021;101:108172. [PMID: 34601331 DOI: 10.1016/j.intimp.2021.108172] [Reference Citation Analysis]
154 Masood KI, Yameen M, Ashraf J, Shahid S, Mahmood SF, Nasir A, Nasir N, Jamil B, Ghanchi NK, Khanum I, Razzak SA, Kanji A, Hussain R, E Rottenberg M, Hasan Z. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Sci Rep 2021;11:22958. [PMID: 34824360 DOI: 10.1038/s41598-021-02489-4] [Reference Citation Analysis]
155 Shulman JG, Ford T, Cervantes-Arslanian AM. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol Clin 2021;39:671-87. [PMID: 33896538 DOI: 10.1016/j.ncl.2021.02.007] [Reference Citation Analysis]
156 Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, Wang L, Tan Y, Wu J, Hao J. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif 2020;53:e12939. [PMID: 33098357 DOI: 10.1111/cpr.12939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
157 Ramezanpour M, Bolt H, Hon K, Bouras GS, Psaltis AJ, Wormald PJ, Vreugde S. Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells. Pathogens 2021;10:848. [PMID: 34357998 DOI: 10.3390/pathogens10070848] [Reference Citation Analysis]
158 Daniel N, Bouras E, Tsilidis KK, Hughes DJ. Genetically Predicted Circulating Concentrations of Micronutrients and COVID-19 Susceptibility and Severity: A Mendelian Randomization Study. Front Nutr 2022;9:842315. [PMID: 35558754 DOI: 10.3389/fnut.2022.842315] [Reference Citation Analysis]
159 Radhakrishnan RK, Kandasamy M. SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia. Am J Alzheimers Dis Other Demen 2022;37:15333175221078418. [PMID: 35133907 DOI: 10.1177/15333175221078418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
160 Koirala S, Anal AK. Probiotics-based foods and beverages as future foods and their overall safety and regulatory claims. Future Foods 2021;3:100013. [DOI: 10.1016/j.fufo.2021.100013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
161 Bonuomo V, Ferrarini I, Dell'Eva M, Sbisà E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review. World J Virol 2021; 10(6): 312-325 [PMID: 34909405 DOI: 10.5501/wjv.v10.i6.312] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
162 Cervantes-arslanian AM, Venkata C, Anand P, Burns JD, Ong CJ, Lemahieu AM, Schulte PJ, Singh TD, Rabinstein AA, Deo N, Bansal V, Boman K, Domecq Garces JP, Lee Armaignac D, Christie AB, Melamed RR, Tarabichi Y, Cheruku SR, Khanna AK, Denson JL, Banner-goodspeed VM, Anderson HL, Gajic O, Kumar VK, Walkey A, Kashyap R; on behalf of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic. Critical Care Explorations 2022;4:e0686. [DOI: 10.1097/cce.0000000000000686] [Reference Citation Analysis]
163 Musial C, Gorska-Ponikowska M. Medical progress: Stem cells as a new therapeutic strategy for COVID-19. Stem Cell Res 2021;52:102239. [PMID: 33601098 DOI: 10.1016/j.scr.2021.102239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Tseng YH, Chen TH. Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era. Front Neurol 2021;12:607790. [PMID: 33841296 DOI: 10.3389/fneur.2021.607790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Abadijoo H, Khayamian MA, Faramarzpour M, Ghaderinia M, Simaee H, Shalileh S, Yazdanparast SM, Ghabraie B, Makarem J, Sarrami-forooshani R, Abdolahad M. Healing Field: Using Alternating Electric Fields to Prevent Cytokine Storm by Suppressing Clonal Expansion of the Activated Lymphocytes in the Blood Sample of the COVID-19 Patients. Front Bioeng Biotechnol 2022;10:850571. [DOI: 10.3389/fbioe.2022.850571] [Reference Citation Analysis]
166 Acherjee T, Behara A, Saad M, Vittorio TJ. Mechanisms and management of prothrombotic state in COVID-19 disease. Ther Adv Cardiovasc Dis 2021;15:17539447211053470. [PMID: 34693818 DOI: 10.1177/17539447211053470] [Reference Citation Analysis]
167 Hingorani KS, Bhadola S, Cervantes-arslanian AM. COVID-19 and the Brain. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
168 Kočar E, Režen T, Rozman D. Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158849. [PMID: 33157278 DOI: 10.1016/j.bbalip.2020.158849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
169 Aykal G, Esen H, Seyman D, Çalışkan T. Could IL-6 predict the clinical severity of COVID-19? Turkish Journal of Biochemistry 2021;46:499-507. [DOI: 10.1515/tjb-2021-0020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Crespo-Facorro B, Ruiz-Veguilla M, Vázquez-Bourgon J, Sánchez-Hidalgo AC, Garrido-Torres N, Cisneros JM, Prieto C, Sainz J. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol 2021;12:646701. [PMID: 33762960 DOI: 10.3389/fphar.2021.646701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
171 Khatiwada S, Subedi A. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19). Curr Nutr Rep 2021;10:125-36. [PMID: 33835432 DOI: 10.1007/s13668-021-00354-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
172 Zaffanello M, Piacentini G, Nosetti L, Ganzarolli S, Franchini M. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature. Thromb Res 2021;205:92-8. [PMID: 34293539 DOI: 10.1016/j.thromres.2021.07.011] [Reference Citation Analysis]
173 Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021;22:e13313. [PMID: 34269511 DOI: 10.1111/obr.13313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, Wippermann J, Michels G. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses 2021;13:1346. [PMID: 34372552 DOI: 10.3390/v13071346] [Reference Citation Analysis]
175 Fadel HH, Ahmed MAE, Gharbeya KM, Mohamed MAK, Roushdy MN, Almiry R. Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients. Dis Markers 2022;2022:6780710. [PMID: 35655915 DOI: 10.1155/2022/6780710] [Reference Citation Analysis]
176 Bhaskar S, Tan J, Bogers MLAM, Minssen T, Badaruddin H, Israeli-Korn S, Chesbrough H. At the Epicenter of COVID-19-the Tragic Failure of the Global Supply Chain for Medical Supplies. Front Public Health 2020;8:562882. [PMID: 33335876 DOI: 10.3389/fpubh.2020.562882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
177 Moonis G, Filippi CG, Kirsch CFE, Mohan S, Stein EG, Hirsch JA, Mahajan A. The Spectrum of Neuroimaging Findings on CT and MRI in Adults With COVID-19. American Journal of Roentgenology 2021;217:959-74. [DOI: 10.2214/ajr.20.24839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
178 Zhou X, Münch G, Wohlmuth H, Afzal S, Kao M(, Al-khazaleh A, Low M, Leach D, Li CG. Synergistic Inhibition of Pro-Inflammatory Pathways by Ginger and Turmeric Extracts in RAW 264.7 Cells. Front Pharmacol 2022;13:818166. [DOI: 10.3389/fphar.2022.818166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Vetrugno L, Sala A, Orso D, Meroi F, Fabbro S, Boero E, Valent F, Cammarota G, Restaino S, Vizzielli G, Girometti R, Merelli M, Tascini C, Bove T, Driul L; PINK-CO study investigators. Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The "PINK-CO" Observational Study. Front Med (Lausanne) 2021;8:768261. [PMID: 35127744 DOI: 10.3389/fmed.2021.768261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Gonçalves de Andrade E, Šimončičová E, Carrier M, Vecchiarelli HA, Robert MÈ, Tremblay MÈ. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic. Front Cell Neurosci 2021;15:647378. [PMID: 33737867 DOI: 10.3389/fncel.2021.647378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]